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Abstract 
 
The present study investigated the effects of microinjections of acetylcholine (a cholinergic 
agonist), physostigmine (a cholinesterase inhibitor), atropine (an antagonist of muscarinic 
cholinergic receptors) and hexamethonium (an antagonist of nicotinic cholinergic receptors) 
into the parafascicular nucleus of thalamus on the acute corneal nociception in rats. Acute 
corneal nociception was induced by putting a drop of 5 M NaCl solution onto the corneal 
surface of the eye and the number of eye wipes was counted during the first 30s. Both 
acetylcholine and physostigmine at the same doses of 0.5, 1 and 2 μg significantly (P < 0.05) 
reduced the number of eye wipes. The intensity of corneal nociception was not changed when 
atropine and hexamethonium were used alone. Atropine (4 μg), but not hexamethonium (4 μg) 
significantly (P  <  0.05)  prevented  acetylcholine  (2  μg)-  and  physostigmine  (2  μg)-induced 
antinociceptive effects. The results indicated that at the level of the parafascicular nucleus of 
thalamus, the muscarinic cholinergic receptors might be involved in the antinociceptive effects 
of acetylcholine and physostigmine. 
 
 
 
Introduction 
 
Parafascicular nucleus, the main intralaminar nucleus 
of the thalamus, is involved in modulating many 
functions of brain such as learning and memory, 
processing of motor information and control of epileptic 
seizures.1-3  Several studies suggest important roles for 
parafascicular nucleus in mediating pain and analgesia. 
Noxious peripheral stimulation increases c-fos-like 
protein expression in parafascicular nucleus.4 
Microinjection of a 5-hydroxytriptamine (5-HT)  1A/7 
receptor agonist, 8-hydroxy-dipropylaminotetralin (8-
OH-DPAT), into parafascicular nucleus produced 
antinociception in rats.5  Moreover, intra-parafascicular 
nucleus administration of morphine increased the 
vocalization threshold induced by noxious tail-shock, 
and methylnaloxonium, a mu-opiate receptor antagonist, 
reversed the antinociceptive effect of morphine.6  
  
 
The roles of acetylcholine, cholinergic agonists and 
cholinesterase inhibitors, collectively termed 
cholinomimetics, have been established in the 
modulation of pain and analgesia.7 The antinociceptive 
effects induced by microinjection of acetylcholine, 
pilocarpine and charbacol in the brain nuclei and regions 
including central amygdale, hippocampus and dentate 
gyrus  have been reported.8-10  Naguib and Yaksh11 
reported the involvement of muscarinic, but not 
nicotinic cholinergic receptors in the antinociception 
induced by intrathecal injections of neostigmine and 
edrophonium in the radiant heat-evoked hind paw 
withdrawal in rats.  Thus far, only one study has 
investigated the involvement of brain muscarinic 
receptors in the physostigmine-induced antinociception 
in the formalin test in rats.12 227                                           E. Tamadonfard et al. Veterinary Research Forum. 2011; 2 (4) 226 - 230   
The present study was aimed to investigate the effects 
of microinjections of acetylcholine (a cholinergic agonist), 
physostigmine (a cholinesterase inhibitor), atropine (an 
antagonist of muscarinic cholinergic receptors) and 
hexamethonium (an antagonist of nicotinic cholinergic 
receptors) on the acute corneal pain in rats. The eye 
wiping induced by local application of 5 M NaCl solution 
and capsaicin onto the corneal surface has been 
introduced as a sensitive animal model for the study of 
acute corneal pain.13-16 
 
Materials and Methods 
 
Animals. Healthy adult male Wistar rats, weighing 280–
320 g were used in this study. Rats were maintained in 
polyethylene cages with food and water available ad libitum 
in a laboratory with controlled ambient temperature (22 ± 
0.5 °C) and under a 12 h light-dark cycle (lights on from 
07:00 h). Six rats were used in each experiment. 
Experiments were performed between 13:00 h and 16:00 
h. All research and animal care procedures were approved 
by the Veterinary Ethics Committee of the Faculty of 
Veterinary Medicine of Urmia University and were 
performed in accordance with the National Institutes of 
Health Guide for Care and Use of Laboratory Animals.17,18  
Drugs.  Drugs used in the present study included 
acetylcholine hydrobromide (Sigma-Aldrich), phsostigmine 
(Sigma-Aldrich), atropine sulphate (Sigma–Aldrich) and 
hexamethonium chloride (Sigma–Aldrich). All drugs were 
dissolved in sterile normal saline 30 min before intra-
parafascicular nucleus microinjection. 
Surgical procedure. To deliver the compounds to be 
tested, two 24-gauge guide cannulas were bilaterally 
implanted in the parafascicular nucleus of thalamus of 
the brain using a stereotaxic apparatus (Stoelting, Wood 
Lane, IL, USA). The tip of cannulas was aimed at the 
following coordinates: 4.3 mm posterior to the bregma, 
1.4 mm left and right sides of the midline and 5.4-6.2 mm 
below the top of the skull.19  The cannulas were then 
fixed to the skull using three screws and dental acrylic 
(Acropars, Tehran, Iran). At least 14 days were allowed 
for recovery from the surgery. 
Intra-parafascicular nucleus microinjection.  Intra-
parafascicular nucleus microinjections of normal saline 
(control), acetylcholine and physostigmine at the same 
doses of 0.25, 0.5, 1 and 2 µg and atropine and 
hexamethonium at the same doses of 1 and 4 µg were 
performed using a 1 µL Hamilton syringe. The volume of the 
drug solution to be injected into each parafascicular nucleus 
was 0.25 µL, and the injection was slowly made over a period 
of 1 min. Intra-parafascicular nucleus microinjections of 
atropine  and hexamethonium were performed 10 min 
before topical corneal surface application of hypertonic 
saline. Acetylcholine and physostigmine were microinjected 
5 min before induction of corneal pain. 
  Corneal nociception.  Corneal nociception was 
induced according to Farazifard et al.13  and 
Tamaddonfard  et al.14,15  Briefly, rats were placed on 
wooden tables. After a 15 min adaptation period, one 
drop (40 µL) of 5 M NaCl solution was applied locally 
onto the corneal surface using a fine dropper and then 
the number of eye wipes performed with the ipsilateral 
forelimb was counted for a period of 30s. Thereafter, the 
eye was washed by local corneal surface application of 
distilled water. Control groups received one drop of 
distilled water applied locally on the corneal surface. 
Cannula verification. At the end of each experiment, 
0.25  µL  metylene blue was injected into the each 
parafascicular nucleus. The animals were euthanized 
with high dose ether, and perfused intracardially with 
physiological saline followed by 10 % formalin solution. 
Brains were removed and placed in the formalin (10 %) 
solution. At least 3 days later, the brains were sectioned 
coronally (50-100 µm), and viewed under a loupe to 
localize the injection site (Fig. 1).19 
Statistical analysis. To evaluate significance 
differences among intra-parafascicular nucleus treated 
groups, one-way analysis of variance (ANOVA) and 
Duncanۥ  s test were applied. In figures, all values are 
expressed as the mean ± SEM. A value of P < 0.05 was 
considered statistically significant. 
 
Results 
 
Placement of the tip of the cannulas in the parafascicular 
nucleus of the brain of rats is shown in Fig. 1. The rat brain 
section was modified from the atlas of Paxinos and Watson19 
(Fig. 1A). The location of the cannula tip placements in the 
parafascicular nucleus was confirmed with intra-
parafascicular nucleus injection of methylene blue (Fig. 1B).  
 
 
 
 
 
 
 
Fig 1. Verified section was taken from the atlas of Paxinos and 
Watson17 (A). The black circles represent the cannula tip placement. 
Location of the injection cannula tips in the parafascicular nucleus of 
all rats were included in the data analysis (B). 
 
Figure 2 shows the effects of intra- parafascicular nucleus 
microinjections of acetylcholine and physostigmine on the 
hypertonic saline-induced corneal pain. Intra-parafascicular 
nucleus microinjections of acetylcholine and physostigmine 
at the same dose of 0.25 µg produced no significant effects 
on the corneal pain intensity, whereas at the same doses of 
0.5, 1 and 2 µg, acetylcholine and physostigmine significantly 
(P < 0.05) decreased the number of eye wipes induced by 
local corneal surface application of hypertonic saline (Fig. 2). 
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Fig 2. Effects of intra-parafascicular microinjection of 
acetylcholine and physostigmine on the hypertonic saline-induced 
acute corneal pain response in rats. * P < 0.05 as compared with 
normal saline (control) group, n = 6 rats in each group. 
 
Figure  3 shows the effects of intra-  parafascicular 
nucleus microinjection of atropine and hexamethonium 
alone on the corneal nociception. Microinjections of 
atropine and hexamethonium at the same doses of 1 and 
4 μg into the parafascicular nucleus of thalamus did not 
change intensity of corneal pain (Fig. 3). 
 
 
 
 
 
 
 
 
 
 
 
Fig 3. Effects of intra-parafascicular microinjection of atropine and 
hexamethonium on the hypertonic saline-induced acute corneal pain 
response in rats. n = 6 rats in each group. 
 
Figure  4 shows the effects of intra-parafascicular 
microinjections of atropine and hexamethonium on 
acetylcholine- and physostigmine-induced antinociception 
in the corneal pain. Microinjection of atropine (4 µg) prior 
to acetylcholine (2 µg) and physostigmine (2 µg) into the 
parafascicular nucleus significantly (P < 0.05) inhibited the 
suppressive effect of acetylcholine and physostigmine on 
the corneal nociception. Hexamethonium (4 µg) did not 
prevent  acetylcholine  (2 µg) - and  physostigmine (2 µg)- 
induced corneal antinociception before acetylcholine and 
physostigmine had been microinjected into the 
parafascicular nucleus (Fig. 4). 
 
Discussion 
In the present study, local corneal surface application of 
a 5 M NaCl solution produced corneal nociception. 
Hypertonic saline was applied to the tongue, and cornea 
transiently activated wide dynamic range nociceptive 
neurons in the trigeminal subnucleus caudalis.20 Farazifard  
   
 
 
 
 
 
 
 
 
 
 
Fig 4. Effects of intra-parafascicular microinjection 
pretreatments with atropine and hexamethonium on the 
acetylcholine-  and physostigmine-induced antinociceptive 
effects in the acute corneal pain in rats. * P < 0.05 as compared 
with other groups, n = 6 rats in each group. Ach: acetylcholine, 
Hex: hexamethonium, Physos: physostigmine. 
 
 
et al.13  introduced the eye wiping induced by local 
application of 5 M NaCl on the corneal surface, as a 
sensitive animal model for behavioral study of acute 
trigeminal pain originating from cornea. In hypertonic 
saline model of acute corneal pain, the antinociceptive 
effect of intracerebroventricular (ICV) injection of 
histamine was reported.14,15  However, the results 
presented here is in agreement with the other findings.13-15 
In this study, intra-parafascicular nucleus microinjections of 
acetylcholine and physostigmine produced antinociceptive 
effects in the acute corneal pain. This finding indicated that in 
the thalamic nuclei such as parafascicular nucleus, the 
cholinergic system might modulate the corneal nociception. 
Intraventricular administration of acetylcholine attenuated 
the increased firing of parafascicular nucleus neurons in 
response to noxious stimulation.21 Moreover, distribution of 
acetylcholine in the thalamic nuclei including dorsolateral 
geniculate, parafascicular nucleus and reticular nuclei has 
been reported in rats.22  In addition, microinjection of 
carbachol, a cholinergic agonist, into the parafascicular 
nucleus increased vocalization threshold induced by tail-
shock in rats.23 Physostigmine is a major alkaloid found in 
seeds of the fabaceous plant Physostigma venenosum, and is 
a powerful and reversible acetylcholine esterase inhibitor 
that effectively increases concentration of acetylcholine in 
the sites of cholinergic transmission.24,25 Most studies have 
focused on effects of acetylcholine esterase inhibitors such 
as physostigmine and neostigmine at the spinal cord 
levels.11,26,27  By ICV route of administration of 
physostigmine, it was reported that physostigmine 
produced an antinociceptive effect in the formalin test in 
rats.12  Moreover, physostigmine reduced synaptic 
transmission in periaqueductal grey, the area involved in 
organizing the behavioral responses to threat, stress and 
pain.28 In the present study, prior microinjected atropine, 
but not hexamethonium, prevented the antinociceptive 
effects induced by acetylcholine and physostigmine. This  
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result  indicates that the muscarinic, but not nicotinic, 
cholinergic receptors in the parafascicular nucleus are 
involved in acetylcholine-  and physostigmine-induced 
antinociceptive effects. An ultrastructural examination of 
the muscarinic receptor population in parafascicular 
nucleus does  not exist, nonetheless, the observation that 
muscarinic induced antinociception persists following the 
depletion of acetylcholine suggests that post-synaptic 
muscarinic receptors are responsible for pain modulation.27 
In the formalin test in rats, the aninociceptive effects 
induced by ICV injection of physostigmine was blocked by 
prior ICV injection of atropine.12  Moreover, atropine 
blocked the antinociceptive effect of carbachol when 
microinjected prior to carbachol into the parafascicular 
nucleus  of thalamus.23  In the present study, 
hexamethonium did not prevent physostigmine-induced 
antinociception. Hexamethonium acts at the peripheral 
tissue levels.30 On the other hand, subcutaneous injection of 
mecamylamine, a centrally acting antagonist of nicotinic 
cholinergic receptors, did not inhibit the antiallodynic effect 
of SC injected of physostigmine in a rat model of 
neuropathic pain.31 Moreover, the intrathecal injection of 
mechamylamine did not prevent physostigmine-  and 
neostigmine-induced antinociception in the formalin test in 
rats.26 It has been reported that the nociceptive information 
from the cornea conveys to the spinal trigeminal nucleus 
part caudalis.32 The spinal trigeminal nucleus part caudalis 
projects directly to higher brain structures involved in pain 
processing, such as medial division of the ventroposterior 
thalamic nucleus, the posterior thalamic nuclear group and 
intralaminar nuclei.33,34  The parafascicular nucleus is the 
main intralaminar nucleus of the thalamus, and various 
neurotransmitters and neuropeptides including serotonin, 
acetylcholine, neuropeptide FF and opiate system are 
involved in parafascicular nucleus mediating pain and 
analgesia mechanisms.5,6,21,23,35 
In conclusion, the results of the present study indicate 
that in the parafasciular nucleus of thalamus, endogenously 
activated acetylcholine by microinjection of physostigmine 
or exogenous microinjection of acetylcholine produced 
antinociception in the hypertonic saline induced corneal 
nociception.    The muscarinic receptors, but not nicotinic 
receptors, may be involved in the antinociceptive effect of 
activated acetylcholine.  
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